Short Interest in NRx Pharmaceuticals, Inc. (NASDAQ:NRXPW) Grows By 225.0%

NRx Pharmaceuticals, Inc. (NASDAQ:NRXPW) was the recipient of a large growth in short interest during the month of November. As of November 30th, there was short interest totalling 3,900 shares, a growth of 225.0% from the November 15th total of 1,200 shares. Based on an average daily trading volume, of 4,900 shares, the days-to-cover ratio is presently 0.8 days.

NRx Pharmaceuticals Trading Down 8.8 %

NRXPW stock traded down $0.01 on Wednesday, reaching $0.06. 2,780 shares of the company’s stock were exchanged, compared to its average volume of 15,709. The stock has a fifty day moving average of $0.06 and a 200-day moving average of $0.07. NRx Pharmaceuticals has a twelve month low of $0.04 and a twelve month high of $0.39.

About NRx Pharmaceuticals

NRx Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. Its products include NRX-101 (D-cycloserine/Lurasidone), an oral, fixed dosed combination of D-cycloserine and lurasidone that earned FDA-designated breakthrough therapy for suicidal treatment-resistant bipolar depression; and NRX-100 (ketamine), which has been awarded FDA fast track designation for the treatment of severe bipolar depression with acute suicidal ideation and behavior.